CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Generation Bio Co. - GBIO CFD

    1.10
    2.65%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.05
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Generation Bio Co ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 1.13
    Open* 1.13
    1-Year Change* -80.11%
    Day's Range* 1.08 - 1.14
    52 wk Range 0.86-7.35
    Average Volume (10 days) 871.24K
    Average Volume (3 months) 11.96M
    Market Cap 75.99M
    P/E Ratio -100.00K
    Shares Outstanding 66.08M
    Revenue 3.03M
    EPS -1.98
    Dividend (Yield %) N/A
    Beta 2.52
    Next Earnings Date Feb 21, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 28, 2023 1.10 -0.06 -5.17% 1.16 1.16 1.08
    Nov 27, 2023 1.13 -0.07 -5.83% 1.20 1.20 1.11
    Nov 24, 2023 1.18 0.02 1.72% 1.16 1.21 1.16
    Nov 22, 2023 1.12 0.00 0.00% 1.12 1.15 1.09
    Nov 21, 2023 1.13 -0.09 -7.38% 1.22 1.24 1.13
    Nov 20, 2023 1.23 0.08 6.96% 1.15 1.28 1.13
    Nov 17, 2023 1.11 0.02 1.83% 1.09 1.13 1.08
    Nov 16, 2023 1.09 -0.07 -6.03% 1.16 1.18 1.04
    Nov 15, 2023 1.16 -0.05 -4.13% 1.21 1.31 1.16
    Nov 14, 2023 1.23 0.04 3.36% 1.19 1.25 1.19
    Nov 13, 2023 1.15 0.06 5.50% 1.09 1.20 1.08
    Nov 10, 2023 1.12 0.01 0.90% 1.11 1.14 1.03
    Nov 9, 2023 1.01 -0.11 -9.82% 1.12 1.15 1.00
    Nov 8, 2023 1.15 -0.08 -6.50% 1.23 1.24 1.08
    Nov 7, 2023 1.20 0.05 4.35% 1.15 1.24 1.13
    Nov 6, 2023 1.14 -0.17 -12.98% 1.31 1.34 1.12
    Nov 3, 2023 1.30 0.29 28.71% 1.01 1.39 0.97
    Nov 2, 2023 0.98 0.04 4.26% 0.94 1.05 0.94
    Nov 1, 2023 0.95 0.03 3.26% 0.92 0.96 0.88
    Oct 31, 2023 0.91 0.01 1.11% 0.90 0.94 0.89

    Generation Bio Co. Events

    Time (UTC) Country Event
    Wednesday, February 21, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 Generation Bio Co Earnings Release
    Q4 2023 Generation Bio Co Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0 0 0 0 0.036
    Revenue 0 0.036
    Total Operating Expense 141.182 119.101 81.114 62.302 37.33
    Selling/General/Admin. Expenses, Total 44.464 33.854 22.582 12.168 9.178
    Research & Development 90.918 85.247 58.532 50.134 28.152
    Operating Income -141.182 -119.101 -81.114 -62.302 -37.294
    Interest Income (Expense), Net Non-Operating 4.543 -0.05 0.591 0.985 1.491
    Net Income Before Taxes -136.639 -119.151 -80.523 -61.317 -35.803
    Net Income After Taxes -136.639 -119.151 -80.523 -61.317 -35.803
    Net Income Before Extra. Items -136.639 -119.151 -80.523 -61.317 -35.803
    Net Income -136.639 -119.151 -80.523 -61.317 -35.803
    Income Available to Common Excl. Extra. Items -136.639 -119.151 -80.523 -61.317 -35.803
    Income Available to Common Incl. Extra. Items -136.639 -119.151 -80.523 -61.317 -35.803
    Diluted Net Income -136.639 -119.151 -80.523 -61.317 -35.803
    Diluted Weighted Average Shares 58.1149 56.2954 46.2919 57.6958 57.6958
    Diluted EPS Excluding Extraordinary Items -2.35119 -2.11653 -1.73946 -1.06276 -0.62055
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS -2.25139 -2.11653 -1.73946 -1.06276 -0.62055
    Unusual Expense (Income) 5.8
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 0.88 0 0 0 0
    Total Operating Expense 34.799 34.866 34.688 32.669 38.481
    Selling/General/Admin. Expenses, Total 12.967 12.866 13.081 11.477 10.116
    Research & Development 21.832 22 20.807 21.192 23.365
    Operating Income -33.919 -34.866 -34.688 -32.669 -38.481
    Interest Income (Expense), Net Non-Operating 2.853 2.772 2.283 1.363 0.552
    Net Income Before Taxes -31.066 -32.094 -32.405 -31.306 -37.929
    Net Income After Taxes -31.066 -32.094 -32.405 -31.306 -37.929
    Net Income Before Extra. Items -31.066 -32.094 -32.405 -31.306 -37.929
    Net Income -31.066 -32.094 -32.405 -31.306 -37.929
    Income Available to Common Excl. Extra. Items -31.066 -32.094 -32.405 -31.306 -37.929
    Income Available to Common Incl. Extra. Items -31.066 -32.094 -32.405 -31.306 -37.929
    Diluted Net Income -31.066 -32.094 -32.405 -31.306 -37.929
    Diluted Weighted Average Shares 65.6562 60.2301 59.4207 58.8723 57.1495
    Diluted EPS Excluding Extraordinary Items -0.47316 -0.53286 -0.54535 -0.53176 -0.66368
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.47316 -0.53286 -0.53189 -0.53176 -0.57619
    Unusual Expense (Income) 0.8 5
    Revenue 0.88
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 287.016 379.186 267.735 18.156 76.926
    Cash and Short Term Investments 279.091 375.145 262.327 15.076 74.87
    Cash & Equivalents 93.171 375.145 62.889 15.076 7.305
    Short Term Investments 185.92 0 199.438 0 67.565
    Total Receivables, Net 0.395 0 0.448 1.288
    Accounts Receivable - Trade, Net 0.395 0 0.448 1.288
    Prepaid Expenses 7.53 4.041 5.408 2.577 0.714
    Other Current Assets, Total 0 0.055 0.054
    Total Assets 376.264 476.771 294.155 42.14 83.519
    Property/Plant/Equipment, Total - Net 81.423 91.029 23.781 21.845 4.486
    Property/Plant/Equipment, Total - Gross 95.961 101.045 29.443 24.075 4.875
    Accumulated Depreciation, Total -14.538 -10.016 -5.662 -2.23 -0.389
    Other Long Term Assets, Total 7.825 6.556 2.639 2.139 2.107
    Total Current Liabilities 19.15 18.808 11.22 9.158 6.555
    Accounts Payable 0.662 2.023 0.267 2.251 1.681
    Accrued Expenses 18.062 16.109 8.862 5.218 3.958
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0.426 0.676 2.091 1.689 0.916
    Total Liabilities 93.771 95.025 26.142 25.139 9.517
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 74.621 76.217 14.922 15.981 2.962
    Total Equity 282.493 381.746 268.013 17.001 74.002
    Redeemable Preferred Stock 0 0 0 115.822 115.822
    Preferred Stock - Non Redeemable, Net -0.229 -0.229
    Common Stock 0.006 0.006 0.005 0.001 0.001
    Additional Paid-In Capital 727.335 689.866 456.974 9.859 5.552
    Retained Earnings (Accumulated Deficit) -444.765 -308.126 -188.975 -108.452 -47.135
    Other Equity, Total -0.083 0 0.009 0 -0.009
    Total Liabilities & Shareholders’ Equity 376.264 476.771 294.155 42.14 83.519
    Total Common Shares Outstanding 59.5054 56.9696 46.2919 57.6958 57.6958
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 297.809 320.623 344.733 287.016 310.558
    Cash and Short Term Investments 291.025 314.143 288.649 279.091 301.169
    Cash & Equivalents 93.36 144.97 95.65 93.171 134.487
    Short Term Investments 197.665 169.173 192.999 185.92 166.682
    Prepaid Expenses 6.124 6.14 6.77 7.53 8.994
    Total Assets 381.492 404.883 431.417 376.264 402.799
    Property/Plant/Equipment, Total - Net 76.79 77.802 79.975 81.423 84.561
    Other Long Term Assets, Total 6.893 6.458 6.709 7.825 7.68
    Total Current Liabilities 32.819 26.479 22.737 19.15 17.318
    Accounts Payable 2.65 2.328 1.504 0.662 1.693
    Accrued Expenses 17.825 15.48 14.967 18.062 15.255
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 12.344 8.671 6.266 0.426 0.37
    Total Liabilities 149.578 150.596 152.278 93.771 94.05
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 116.759 124.117 129.541 74.621 76.732
    Total Equity 231.914 254.287 279.139 282.493 308.749
    Redeemable Preferred Stock 0 0 0 0
    Common Stock 0.007 0.007 0.007 0.006 0.006
    Additional Paid-In Capital 768.102 762.228 755.957 727.335 721.405
    Retained Earnings (Accumulated Deficit) -536.191 -507.925 -476.859 -444.765 -412.36
    Other Equity, Total -0.004 -0.023 0.034 -0.083 -0.302
    Total Liabilities & Shareholders’ Equity 381.492 404.883 431.417 376.264 402.799
    Total Common Shares Outstanding 65.928 65.7842 65.5357 59.5054 59.2752
    Total Receivables, Net 0.66 0.34 49.314 0.395 0.395
    Accounts Receivable - Trade, Net 0.66 0.34 1.814 0.395 0.395
    Property/Plant/Equipment, Total - Gross 95.224 94.944 95.802 95.961 98.063
    Accumulated Depreciation, Total -18.434 -17.142 -15.827 -14.538 -13.502
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -136.639 -119.151 -80.523 -61.317 -35.803
    Cash From Operating Activities -102.448 -91.821 -70.142 -40.346 -28.119
    Cash From Operating Activities 5.13 4.532 3.432 1.864 0.347
    Non-Cash Items 28.015 18.623 8.661 3.88 2.654
    Changes in Working Capital 1.046 4.175 -1.712 15.227 4.683
    Cash From Investing Activities -192.515 193.047 -205.196 47.985 -69.761
    Capital Expenditures -8.801 -5.958 -5.518 -19.986 -3.021
    Other Investing Cash Flow Items, Total -183.714 199.005 -199.678 67.971 -66.74
    Cash From Financing Activities 12.989 214.671 323.095 0.078 100.189
    Financing Cash Flow Items -0.631 -0.955 -3.226 -0.022 0
    Issuance (Retirement) of Stock, Net 13.62 215.626 326.321 0.1 100.189
    Net Change in Cash -281.974 315.897 47.757 7.717 2.309
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -32.094 -136.639 -104.234 -72.928 -34.999
    Cash From Operating Activities -27.677 -102.448 -79.445 -58.968 -35.435
    Cash From Operating Activities 1.33 5.13 3.784 2.42 1.197
    Non-Cash Items 4.189 28.015 23.044 17.582 6.094
    Changes in Working Capital -1.102 1.046 -2.039 -6.042 -7.727
    Cash From Investing Activities -5.616 -192.515 -174.119 -161.505 -2.784
    Capital Expenditures -0.755 -8.801 -8.119 -7.468 -2.784
    Other Investing Cash Flow Items, Total -4.861 -183.714 -166 -154.037 0
    Cash From Financing Activities 35.772 12.989 12.906 3.593 0.052
    Financing Cash Flow Items -0.228 -0.631 -0.444 -0.05 -0.05
    Issuance (Retirement) of Stock, Net 36 13.62 13.35 3.643 0.102
    Net Change in Cash 2.479 -281.974 -240.658 -216.88 -38.167
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Fidelity Management & Research Company LLC Investment Advisor 12.9556 8541412 -327296 2023-06-30 LOW
    Atlas Venture Venture Capital 12.5583 8279484 0 2023-06-30 LOW
    T. Rowe Price Associates, Inc. Investment Advisor 11.2943 7446147 -150973 2023-06-30 LOW
    Modernatx Inc Corporation 8.8875 5859375 5859375 2023-03-24
    Bellevue Asset Management AG Investment Advisor 5.4912 3620280 0 2023-06-30 LOW
    T. Rowe Price Investment Management, Inc. Investment Advisor 5.3262 3511456 130500 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 4.8857 3221084 103915 2023-06-30 LOW
    Invus Public Equities Advisors, LLC Investment Advisor 4.2685 2814191 0 2023-06-30 MED
    PFM Health Sciences, LP Hedge Fund 3.9398 2597436 -50861 2023-06-30 MED
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.4268 2259259 16609 2023-06-30 LOW
    EcoR1 Capital, LLC Hedge Fund 3.1047 2046867 90288 2023-06-30 LOW
    McDonough (Cameron Geoffrey) Individual Investor 2.7098 1786533 13042 2023-10-15 LOW
    Yiheng Capital Management, L.P. Investment Advisor 2.4296 1601766 0 2023-06-30 LOW
    Great Point Partners, LLC Hedge Fund 1.551 1022537 0 2023-06-30 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.5239 1004698 70941 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.3783 908713 11967 2023-06-30 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.9776 644500 99665 2023-06-30 LOW
    BofA Global Research (US) Research Firm 0.8046 530443 -12357 2023-06-30 LOW
    Harvard Management Company, Inc. Endowment Fund 0.7741 510354 0 2023-06-30 LOW
    JP Morgan Asset Management Investment Advisor 0.7512 495227 404118 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Generation Bio Co. Company profile

    About Generation Bio Co

    Generation Bio Co. is genetic medicines to provide treatments of rare and prevalent diseases. The Company through its non-viral genetic medicine platform, is engaged in developing genetic medicines to provide genetic payloads, which include large and multiple genes to a range of cell types across a range of diseases. It is comprised of three component technologies: ceDNA, ctLNP and ceDNA manufacturing process. ceDNA is an engineered, double-stranded, linear, covalently closed-ended deoxyribonucleic acid (DNA) construct, which includes the gene of interest and associated regulatory sequences. It has produced ceDNA constructs of approximately eight kilobases. Its ctLNP delivery system builds upon clinically validated lipid nanoparticles and is designed to allow for repeat dosing of a genetic payload without stimulating an immune response, such as antibody production. Its ceDNA manufacturing process uses its own cell-free rapid enzymatic synthesis (RES) to produce ceDNA.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Generation Bio Co revenues was not reported. Net loss increased 48% to $119.2M. Higher net loss reflects alancing val increase of 39% to $51M (expense), Labor & Related Expenses in R&D increase of 43% to $24.9M (expense), Stock-based Compensation in R&D increase from $4.3M to $9.3M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.74 to -$2.12.

    Industry: Bio Therapeutic Drugs

    301 Binney Street
    CAMBRIDGE
    MASSACHUSETTS 02142
    US

    Income Statement

    • Annual
    • Quarterly

    News

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    Gold Rises as Traders price-in Fed Rate Cuts

    Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

    13:17, 20 November 2023

    People also watch

    Gold

    2,043.71 Price
    +0.050% 1D Chg, %
    Long position overnight fee -0.0191%
    Short position overnight fee 0.0109%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    Oil - Crude

    76.76 Price
    -0.110% 1D Chg, %
    Long position overnight fee -0.0187%
    Short position overnight fee -0.0032%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    XRP/USD

    0.62 Price
    +0.130% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    US100

    16,039.00 Price
    +0.090% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading